ONC Q3 2025 Earnings — BeOne Medicines Ltd. Revenue & Financial Results | Market Cap Arena

ONCBeOne Medicines Ltd.

$33B

Q3 2025 Earnings

Healthcare Medical - Pharmaceuticals

Income Statement

Revenue

$1.4B+41.0% YoY

Gross Profit

$1.2B86.1% margin

Operating Income

$163M11.5% margin

Net Income

$125M8.8% margin

EPS (Diluted)

$13.52

QoQ Revenue Growth

+7.4%

Cash Flow

Operating Cash Flow

$403M

Free Cash Flow

$354M

Stock-Based Comp.

$141M

Balance Sheet

Total Assets

$7.6B

Total Liabilities

$3.5B

Stockholders' Equity

$4.1B

Cash & Equivalents

$4.0B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.4B	$1.0B	+41.0%
Gross Profit	$1.2B	$831M	+46.3%
Operating Income	$163M	-$120M	+235.6%
Net Income	$125M	-$121M	+202.9%

Revenue Segments

Product

$1.8B100%

Geographic Segments

UNITED STATES

$755M53%

CHINA

$440M31%

Europe

$167M12%

All Other Countries Except China And United States Of America

$51M4%